Fierce Healthcare November 17, 2021
The Biden administration has issued an interim final rule that requires private insurers to report prescription drug costs to the federal government.
The interim rule, which also includes a request for comment, is the latest in a series of regulations implementing provisions of the No Surprises Act and the Consolidated Appropriations Act of 2021. Insurers providing employer-sponsored coverage, other group plans or individual plans must submit key data on drug costs to the departments of Health and Human Services (HHS), Labor and Treasury.
The data will then be used by HHS’ Assistant Secretary for Planning and Evaluation to publish a report on drug pricing trends and rebates along with their impact on insurance premiums and consumers’ out-of-pocket costs, according to...
Today's Sponsors
Today's Sponsor